Advertisement

Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis—an enzyme involved in peptidoglycan biosynthesis

  • Alka Pawar
  • Prakash Jha
  • Chandrika Konwar
  • Uma Chaudhry
  • Madhu Chopra
  • Daman SalujaEmail author
Genomics, transcriptomics, proteomics

Abstract

Increasing drug resistance in pathogens including Mycobacterium tuberculosis (MTB) has been ascribed to mutations in the known target genes. However, many of these drugs have multiple targets; some of which have not been identified so far. Understanding the mechanism of action of these drugs holds a great promise in better management of disease especially by drug-resistant strains. In this study, we report glutamate racemase (MurI), a crucial enzyme of phase I peptidoglycan (PG) biosynthesis pathway of MTB, as an additional target of ethambutol (EMB). The effect on EMB on the MurI protein at structural and functional level was studied using different spectroscopic, biochemical, and insilico approaches. Spectroscopic analysis revealed that EMB-modified protein undergoes conformational alterations. Furthermore, in vitro racemization studies of the MurI protein suggest that EMB decreases its functional activity. Docking studies revealed that EMB interacts with most of the active residues at the binding site and blocks the binding pocket. Overall, data suggests that EMB, a primary drug used for the treatment of tuberculosis (TB), acts as a competitive inhibitor of substrate for binding to mycobacterial MurI protein. The study also points out to our lacunae in understanding the site and mechanism of action of existing drugs. Furthermore, glutamate racemase is a conserved protein of the bacterial kingdom; therefore, ethambutol could be a promising candidate as a broad-spectrum antibiotic for many other bacterial diseases.

Keywords

Mycobacterium tuberculosis Glutamate racemase MurI Peptidoglycan Ethambutol d-glutamate 

Notes

Acknowledgements

The authors thank the Department of Science and Technology (DST) purse grant and MG grant to DS for financial support. The support from Department of Biotechnology, Govt. of India for Bioinformatics Facility at Dr. B.R. Ambedkar Center for Biomedical Research is highly acknowledged. Senior research fellowship to AP from Indian Council for Medical Research and DST-INSPIRE fellowship to PJ from DST is gratefully acknowledged.

Funding information

The project grants, purse grant and MG grant, were received by DST and University of Delhi. Fellowship and contingency grant was provided to AP from ICMR and PJ from DST.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

253_2018_9518_MOESM1_ESM.pdf (767 kb)
ESM 1 (PDF 766 kb)

References

  1. Alvarez HA, McCarthy AN, Grigera JR (2012) A molecular dynamics approach to ligand-receptor interaction in the aspirin-human serum albumin complex. J Biophys 2012:1–7.  https://doi.org/10.1155/2012/642745 CrossRefGoogle Scholar
  2. Amin AG, Goude R, Shi L, Zhang J, Chatterjee D, Parish T (2008) EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154:240–248.  https://doi.org/10.1099/mic.0.2007/012153-0 CrossRefPubMedPubMedCentralGoogle Scholar
  3. Belanger AE, Besra GS, Ford ME, Mikusova K, Belisle JT, Brennan PJ, Inamine JM (1996) The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci 93:11919–11924.  https://doi.org/10.1073/pnas.93.21.11919 CrossRefPubMedGoogle Scholar
  4. Bugg TD, Walsh CT (1992) Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. Nat Prod Rep 9:199–215CrossRefGoogle Scholar
  5. Castonguay F, Dufour JJ, Minvielle F, Estrada R (1990) Follicular dynamics and dominance in Booroola x Finnish Landrace and Booroola x Suffolk ewes heterozygous for the F gene. J Reprod Fertil 89:193–203CrossRefGoogle Scholar
  6. Chen YH, Yang JT, Chau KH (1974) Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry (Mosc) 13:3350–3359CrossRefGoogle Scholar
  7. Epand RM, Walker C, Epand RF, Magarvey NA (2016) Molecular mechanisms of membrane targeting antibiotics. Biochim Biophys Acta BBA - Biomembr 1858:980–987.  https://doi.org/10.1016/j.bbamem.2015.10.018 CrossRefGoogle Scholar
  8. Fisher SL (2008) Glutamate racemase as a target for drug discovery. Microb Biotechnol 1:345–360.  https://doi.org/10.1111/j.1751-7915.2008.00031.x CrossRefPubMedPubMedCentralGoogle Scholar
  9. Gagnon JK, Law SM, Brooks III CL (2014) Flexible CDOCKER: development and application of a pseudo-explicit structure-based docking method within CHARMM. Biophys J 106:646a . doi:  https://doi.org/10.1016/j.bpj.2013.11.3576 CrossRefGoogle Scholar
  10. Gallo KA, Knowles JR (1993) Purification, cloning, and cofactor independence of glutamate racemase from Lactobacillus. Biochemistry (Mosc) 32:3981–3990CrossRefGoogle Scholar
  11. Gallo KA, Tanner ME, Knowles JR (1993) Mechanism of the reaction catalyzed by glutamate racemase. Biochemistry (Mosc) 32:3991–3997.  https://doi.org/10.1021/bi00066a020 CrossRefGoogle Scholar
  12. Glavas S, Tanner ME (1999) Catalytic acid/base residues of glutamate racemase . Biochemistry (Mosc) 38:4106–4113.  https://doi.org/10.1021/bi982663n CrossRefGoogle Scholar
  13. Glavas S, Tanner ME (2001) Active site residues of glutamate racemase . Biochemistry (Mosc) 40:6199–6204.  https://doi.org/10.1021/bi002703z CrossRefGoogle Scholar
  14. Goude R, Amin AG, Chatterjee D, Parish T (2009) The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 53:4138–4146.  https://doi.org/10.1128/AAC.00162-09 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Hasan T, Ali M, Saluja D, Singh LR (2015) pH might play a role in regulating the function of paired amphipathic helices domains of human Sin3B by altering structure and thermodynamic stability. Biochem Biokhimiia 80:424–432.  https://doi.org/10.1134/S0006297915040057 CrossRefGoogle Scholar
  16. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32:40–51.  https://doi.org/10.1038/nbt.2786 CrossRefPubMedGoogle Scholar
  17. Hess B (2008) P-LINCS: a parallel linear constraint solver for molecular simulation. J Chem Theory Comput 4:116–122.  https://doi.org/10.1021/ct700200b CrossRefPubMedGoogle Scholar
  18. Hwang KY, Cho CS, Kim SS, Sung HC, Yu YG, Cho Y (1999) Structure and mechanism of glutamate racemase from Aquifex pyrophilus. Nat Struct Biol 6:422–426.  https://doi.org/10.1038/8223 CrossRefPubMedGoogle Scholar
  19. Lee JY (2015) Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis 78:47–55.  https://doi.org/10.4046/trd.2015.78.2.47 CrossRefGoogle Scholar
  20. Liu Y, Breukink E (2016) The membrane steps of bacterial cell wall synthesis as antibiotic targets. Antibiotics 5:28.  https://doi.org/10.3390/antibiotics5030028 CrossRefPubMedCentralGoogle Scholar
  21. Lundqvist T, Fisher SL, Kern G, Folmer RHA, Xue Y, Newton DT, Keating TA, Alm RA, de Jonge BLM (2007) Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447:817–822.  https://doi.org/10.1038/nature05689 CrossRefPubMedGoogle Scholar
  22. Petersen HG (1995) Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys 103:3668–3679.  https://doi.org/10.1063/1.470043 CrossRefGoogle Scholar
  23. Poen S, Nakatani Y, Opel-Reading HK, Lasse M, Dobson RCJ, Krause KL (2016) Exploring the structure of glutamate racemase from Mycobacterium tuberculosis as a template for anti-mycobacterial drug discovery. Biochem J 473:1267–1280.  https://doi.org/10.1042/BCJ20160186 CrossRefPubMedGoogle Scholar
  24. Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854.  https://doi.org/10.1093/bioinformatics/btt055 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Raviglione M, Sulis G (2016) Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep 8.  https://doi.org/10.4081/idr.2016.6570
  26. Ruzheinikov SN, Taal MA, Sedelnikova SE, Baker PJ, Rice DW (2005) Substrate-induced conformational changes in Bacillus subtilis glutamate racemase and their implications for drug discovery. Struct Lond Engl 1993 13:1707–1713.  https://doi.org/10.1016/j.str.2005.07.024 CrossRefGoogle Scholar
  27. Sengupta S, Ghosh S, Nagaraja V (2008) Moonlighting function of glutamate racemase from Mycobacterium tuberculosis: racemization and DNA gyrase inhibition are two independent activities of the enzyme. Microbiology 154:2796–2803.  https://doi.org/10.1099/mic.0.2008/020933-0 CrossRefPubMedGoogle Scholar
  28. Shehzad A, Rehman G, Ul-Islam M, Khattak WA, Lee YS (2013) Challenges in the development of drugs for the treatment of tuberculosis. Braz J Infect Dis 17:74–81.  https://doi.org/10.1016/j.bjid.2012.10.009 CrossRefPubMedGoogle Scholar
  29. Silhavy TJ, Kahne D, Walker S (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2:a000414.  https://doi.org/10.1101/cshperspect.a000414 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Smith I (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16:463–496.  https://doi.org/10.1128/CMR.16.3.463-496.2003 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85CrossRefGoogle Scholar
  32. Sulis G, Centis R, Sotgiu G, D’Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB (2016) Recent developments in the diagnosis and management of tuberculosis. Npj Prim Care Respir Med 26:16078.  https://doi.org/10.1038/npjpcrm.2016.78 CrossRefPubMedPubMedCentralGoogle Scholar
  33. Szabo AG, Lynn KR, Krajcarski DT, Rayner DM (1978) Tyrosinate fluorescence maxima at 345 nm in proteins lacking tryptophan at pH 7. FEBS Lett 94:249–252CrossRefGoogle Scholar
  34. Tanner ME, Gallo KA, Knowles JR (1993) Isotope effects and the identification of catalytic residues in the reaction catalyzed by glutamate racemase. Biochemistry (Mosc) 32:3998–4006CrossRefGoogle Scholar
  35. Tanwar O, Deora GS, Tanwar L, Kumar G, Janardhan S, Alam M, null S, Akhter M (2014) Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations. J Mol Model 20:2118.  https://doi.org/10.1007/s00894-014-2118-7 CrossRefPubMedGoogle Scholar
  36. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR (1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567–570CrossRefGoogle Scholar
  37. Teo A, Roper D (2015) Core steps of membrane-bound peptidoglycan biosynthesis: recent advances, insight and opportunities. Antibiotics 4:495–520.  https://doi.org/10.3390/antibiotics4040495 CrossRefPubMedPubMedCentralGoogle Scholar
  38. van Aalten DM, Bywater R, Findlay JB, Hendlich M, Hooft RW, Vriend G (1996) PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J Comput Aided Mol Des 10:255–262CrossRefGoogle Scholar
  39. Walsh CT (1989) Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem 264:2393–2396PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Alka Pawar
    • 1
    • 2
  • Prakash Jha
    • 1
  • Chandrika Konwar
    • 1
  • Uma Chaudhry
    • 2
  • Madhu Chopra
    • 1
  • Daman Saluja
    • 1
    Email author
  1. 1.Dr. B. R. Ambedkar Center for Biomedical ResearchUniversity of DelhiDelhiIndia
  2. 2.Bhaskaracharya College of Applied SciencesUniversity of DelhiDelhiIndia

Personalised recommendations